Gsk (GSK) EBT (2009 - 2026)
Gsk's EBT came in at $3.35 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) EBT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 8, 2026, Gsk reported EBT of $3.45 billion; for the year ended Dec 31, 2025, it came in at $9.76 billion, up 119.6% from the prior year.
- EBT carries a five-year compound annual growth rate of 8.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, EBT was $4.44 billion in the year ended Dec 31, 2024 (-41.1%), $7.54 billion in the year ended Dec 31, 2023 (+8.3%), $6.97 billion in the year ended Dec 31, 2022 (+40.7%) and $4.95 billion in the year ended Dec 31, 2021 (-25.4%).
- The figure for the quarter ended Sep 8, 2026 represents the highest quarterly EBT since the quarter ended Dec 31, 2020.
- Year-over-year, EBT increased in four of the last five quarters, with growth averaging 13.8%.
- The fastest year-over-year change in EBT over five years came in the quarter ended Dec 31, 2022 (growth of 366.9%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 96.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 474.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 474.95 Mn |
| Mar 31, 2026 | 2.89 Bn |
| Dec 31, 2025 | -3.27 Bn |
| Sep 30, 2025 | 3.31 Bn |
| Jun 30, 2025 | 2.52 Bn |
| Mar 31, 2025 | 2.66 Bn |
| Dec 31, 2024 | 722.61 Mn |
| Sep 30, 2024 | 83.16 Mn |
| Jun 30, 2024 | 1.89 Bn |
| Mar 31, 2024 | 1.72 Bn |
| Dec 31, 2023 | 470.40 Mn |
| Sep 30, 2023 | 2.27 Bn |
| Jun 30, 2023 | 2.49 Bn |
| Mar 31, 2023 | 2.32 Bn |
| Dec 31, 2022 | 1.91 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 2.81 Bn |
| Dec 31, 2021 | 408.45 Mn |
| Sep 30, 2021 | 1.64 Bn |
API Access
Gsk EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();